• Every dose printed on the panel
  • Prices shown per serving
  • Cautions printed on the page
  • 30-day money-back guarantee

Research review

Does zinc help with diabetes? What the research does and doesn't show

Two meta-analyses (2013 and 2019) found small, statistically significant reductions in fasting glucose and HbA1c with zinc supplementation, concentrated in people who already had diabetes or a related metabolic condition — not in the general population, and not at any one established dose.

By Electric Tiger Editorial

The evidence doesn't support zinc as a treatment for diabetes. It does show a real effect in people who already have it: a 2019 meta-analysis of 32 randomized trials found fasting glucose and HbA1c were both lower with zinc than with placebo in people with diabetes, though the effect was much smaller across general, mostly non-diabetic populations.

What the evidence doesn't support

It doesn't support zinc as a treatment for diagnosed diabetes, a replacement for diabetes medication, or a specific dose guaranteed to move blood sugar by a set amount — neither meta-analysis below pooled a single dose across its trials. It also doesn't support treating a mineral supplement as a substitute for insulin or other prescribed medication; the trials used zinc alongside usual care, not instead of it.

What the trials found

A 2019 systematic review and meta-analysis in the American Journal of Clinical Nutrition (Wang et al.) pooled 32 placebo-controlled trials (1,700 participants across 14 countries) of oral zinc supplementation for diabetes prevention and management. Fasting glucose was 14.15 mg/dL lower with zinc than with placebo (95% CI -17.36 to -10.93 mg/dL), and 2-hour post-meal glucose was 36.85 mg/dL lower. HbA1c was 0.55 percentage points lower too (95% CI -0.84 to -0.27%). A subgroup analysis found the fasting-glucose effect was larger in trials of people who already had diabetes, and larger with an inorganic zinc supplement than an organic one. The review didn't pool one dose or duration across the 32 trials — the studies varied. Its authors described the finding as support for zinc as a possible add-on alongside usual care for diabetes, not as a primary treatment.

A separate 2013 meta-analysis in the Journal of Trace Elements in Medicine and Biology pooled 14 reports (3,978 participants) of randomized, placebo-controlled zinc trials, searched through 2011. Across all participants combined, fasting glucose was about 0.19 mmol/L lower with zinc than with placebo (p=0.013) — a small but statistically significant difference — and HbA1c showed a downward trend that didn't reach significance (-0.64%, p=0.072). In a secondary analysis limited to participants with type 1 or type 2 diabetes, metabolic syndrome or obesity, the fasting-glucose difference was larger: about 0.49 mmol/L. Serum insulin didn't differ significantly between groups in either analysis. As with the 2019 review, zinc doses and forms varied across the pooled trials rather than following one protocol.

Measure 2019 review (32 trials, mixed populations) 2013 review (14 trials, all participants)
Fasting glucose 14.15 mg/dL lower with zinc 0.19 mmol/L (about 3.4 mg/dL) lower with zinc
HbA1c 0.55 percentage points lower 0.64% lower, not statistically significant
Effect in people who already had a metabolic condition Larger than in mixed/general subgroups About 0.49 mmol/L lower — roughly 2.5x the overall effect

Questions people ask

Is zinc good for diabetes?

Not established as a treatment: the trials above are add-on studies, run alongside usual diabetes care, not tests of zinc replacing diabetes medication. What they do show is a real, measurable average effect on fasting glucose and HbA1c in people who already have diabetes — bigger in that group than in people without it.

Does zinc lower blood sugar in people without diabetes?

The 2013 meta-analysis above found a small overall effect across all participants combined (about 0.19 mmol/L lower fasting glucose), but that number blends people with and without diabetes, metabolic syndrome or obesity together. The effect was about two and a half times larger in the subgroup with one of those conditions, which suggests most of the overall effect is coming from people with an existing glucose problem, not from otherwise healthy adults.

What dose of zinc did the diabetes trials use?

Neither meta-analysis reported one pooled dose. The trials they reviewed varied in zinc form and amount, and the 2019 review found the size of the effect depended partly on whether the supplement was an organic or inorganic form of zinc, not just how much was taken. There's no single number from this research to print as "the effective dose for diabetes."

Does zinc interact with diabetes medication?

Zinc's glucose-lowering signal in these trials means it could have an additive effect alongside insulin or other glucose-lowering medication — a reason to tell a doctor or pharmacist before adding it, not a reason to combine them untested. See zinc and medications: what to check for zinc's other interactions.

When to talk to a doctor

Diabetes and prediabetes need medical monitoring and management with a doctor, including decisions about medication. Zinc is not a treatment for diabetes, and nothing in the evidence above supports using it as a substitute for blood sugar monitoring, insulin or other prescribed medication. If you take diabetes medication or any other prescription, or are pregnant or nursing, talk to a doctor before adding zinc — an additive glucose-lowering effect alongside medication can push blood sugar lower than intended.

Related reading: zinc benefits: what the research does and doesn't show, blood sugar supplements: what the evidence supports, and zinc and medications: what to check.

Sources

  1. Zinc supplementation improves glycemic control for diabetes prevention and management: a systematic review and meta-analysis of randomized controlled trials The American journal of clinical nutrition · 2019 · PMID 31161192
  2. Zinc and glycemic control: a meta-analysis of randomised placebo controlled supplementation trials in humans Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS) · 2013 · PMID 23137858A 2013 meta-analysis of 14 trials found a small overall reduction in fasting glucose with zinc across all participants, and a larger reduction limited to people who already had diabetes, metabolic syndrome or obesity.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.